Skip to content
Screener

Beta Bionics BBNX Shares (Diluted)

Shares (Diluted) at other companies

Insulet logo
InsuletPODD
69.4M-1.8%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
69M+2.9%
Medtronic logo
MedtronicMDT
1.3B-0.1%
AdaptHealth logo
AdaptHealthAHCO
135.8M+0.7%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
121.2M-2.4%

Other financials

Income statement

See full
Revenue$32.0M+37.8%
Gross profit$18.9M+51.2%
Operating income-$25.6M-28.7%
Net income-$23.4M-38.7%
EPS (diluted)-$0.53-35.9%

Balance sheet

See full
Cash & equivalents$44.3M+26.4%
Total debt$6.5M-2.6%
Total equity$256.4M-15.0%
Total assets$292.4M-11.4%

Cash flow

See full
Operating cash flow-$14.6M-7.6%
CapEx$1.0M-41.6%
Free cash flow-$15.7M-1.9%

Valuation

See full
Market cap$715.34M+15.1%
Enterprise value$677.53M+14.2%
P/S-2.0×

Profitability

See full
Gross margin58.3%+4.4pp
Operating margin-69.8%-8.0pp
Net margin-61.3%-15.8pp
FCF margin-51.6%-13.4pp

Returns & leverage

See full
Return on equity-26.2%
Debt / equity0.0×
Current ratio8.9×-5.8×

Where this comes from

Reported directly by Beta Bionics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Beta Bionics’s 10-Q, filed July 29, 2026. Open the filing →

Filed
Jul 29, 2026, 4:20 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323777

FAQ

What is Beta Bionics's shares (diluted)?
Beta Bionics (BBNX) reported shares (diluted) of 44.5M in Q2 2026.
How has Beta Bionics's shares (diluted) changed year-over-year?
Beta Bionics's shares (diluted) increased by 2.7% year-over-year, from 43.4M to 44.5M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Beta Bionics's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude